CureVac Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio4.55
P/S Ratio1.3815.8715.9254.79239.30
P/B Ratio1.061.652.018.2016.44
Price/Tangible Book1.101.752.148.3516.76
Price/FCF8.4424.06
Price/OCF7.2522.39
Enterprise Value Ratios
EV/Revenue1.068.359.1244.85222.35
EV/EBITDA2.56
EV/EBIT2.71
EV/FCF6.5122.36
Profitability & Returns
Return on Equity (ROE)0.27%-0.50%-0.41%-0.59%-0.39%
Return on Assets (ROA)0.16%-0.20%-0.14%-0.48%-0.10%
Return on Invested Capital (ROIC)0.20%-0.29%-0.22%-0.87%-0.21%
Return on Capital Employed (ROCE)0.29%-0.44%-0.32%-1.29%-0.11%
Leverage & Solvency Ratios
Debt/Equity0.060.080.080.040.08
Debt/EBITDA0.17
Debt/FCF0.450.11
Liquidity Ratios
Current Ratio7.282.573.742.635.61
Quick Ratio7.112.373.442.435.39
Efficiency Ratios
Asset Turnover0.670.070.070.080.06
Inventory Turnover8.344.763.976.091.37
Yield & Distribution Ratios
Earnings Yield0.22%-0.30%-0.23%-0.07%-0.01%
FCF Yield0.12%-0.38%-0.35%-0.15%0.04%
Buyback Yield-0.02%-0.17%-0.02%-0.41%-0.37%